Renaissance Capital logo

Hyperion Therapeutics Priced, Nasdaq: HPTX

Focused on the treatment of orphan diseases of the liver relating to the urea cycle.

Industry: Health Care

First Day Return: +1.1%

Industry: Health Care

Focused on the treatment of orphan diseases of the liver relating to the urea cycle.
more less
IPO Data
IPO File Date 04/13/2012
Offer Price $10.00
Price Range $11.00 - $13.00
Offer Shares (mm) 5.0
Deal Size ($mm) $50
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 07/25/2012
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $50
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters South San Francisco, CA, United States
Founded 2006
Employees at IPO 14
Website www.hyperiontx.com

Hyperion Therapeutics (HPTX) Performance